These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 10694199

  • 21. Influence of endogenous bradykinin on acute blood pressure response to vasopressors in normotensive rats assessed with a bradykinin antagonist.
    Aubert JF, Waeber B, Nussberger J, Vavrek R, Stewart JM, Brunner HR.
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):51-5. PubMed ID: 2450256
    [Abstract] [Full Text] [Related]

  • 22. Cardiovascular and drinking responses elicited by central administration of angiotensin II: differential effects of GABA injected into the ventral tegmental area and spiperone injected into the nucleus accumbens.
    Jones DL.
    Brain Res Bull; 1986 Aug; 17(2):265-9. PubMed ID: 3768735
    [Abstract] [Full Text] [Related]

  • 23. Behavioral and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat.
    Kalivas PW, Burgess SK, Nemeroff CB, Prange AJ.
    Neuroscience; 1983 Mar; 8(3):495-505. PubMed ID: 6406930
    [Abstract] [Full Text] [Related]

  • 24. Lack of effect of a selective vasopressin V1A receptor antagonist SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed.
    Heinemann A, Horina G, Stauber RE, Pertl C, Holzer P, Peskar BA.
    Br J Pharmacol; 1998 Nov; 125(6):1120-7. PubMed ID: 9863637
    [Abstract] [Full Text] [Related]

  • 25. Differential sensitisation to central cardiovascular effects of angiotensin II in rats with a myocardial infarct: relevance to stress and interaction with vasopressin.
    Cudnoch-Jedrzejewska A, Szczepanska-Sadowska E, Dobruch J, Puchalska L, Ufnal M, Kowalewski S, Wsół A.
    Stress; 2008 Jul; 11(4):290-301. PubMed ID: 18574789
    [Abstract] [Full Text] [Related]

  • 26. Neurotensin antagonist acutely and robustly attenuates locomotion that accompanies stimulation of a neurotensin-containing pathway from rostrobasal forebrain to the ventral tegmental area.
    Reynolds SM, Geisler S, Bérod A, Zahm DS.
    Eur J Neurosci; 2006 Jul; 24(1):188-96. PubMed ID: 16882016
    [Abstract] [Full Text] [Related]

  • 27. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine.
    Altier N, Stewart J.
    J Pharmacol Exp Ther; 1998 Apr; 285(1):208-15. PubMed ID: 9536012
    [Abstract] [Full Text] [Related]

  • 28. Blood pressure dependency on vasopressin and angiotensin II in prazosin-treated conscious normotensive rats.
    Waeber B, Nussberger J, Brunner HR.
    J Pharmacol Exp Ther; 1983 May; 225(2):442-6. PubMed ID: 6341543
    [Abstract] [Full Text] [Related]

  • 29. Vasopressin and sympathetic system mediate the cardiovascular effects of the angiotensin II in the bed nucleus of the stria terminalis in rat.
    Nasimi A, Kafami M.
    Neurosci Res; 2016 Jul; 108():34-9. PubMed ID: 26820216
    [Abstract] [Full Text] [Related]

  • 30. Repeated neurotensin administration in the ventral tegmental area: effects on baseline and D-amphetamine-induced locomotor activity.
    Elliott PJ, Nemeroff CB.
    Neurosci Lett; 1986 Jul 24; 68(2):239-44. PubMed ID: 3748452
    [Abstract] [Full Text] [Related]

  • 31. Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat.
    Hagan RM, Jones BJ, Jordan CC, Tyers MB.
    Br J Pharmacol; 1990 Feb 24; 99(2):227-32. PubMed ID: 1691672
    [Abstract] [Full Text] [Related]

  • 32. Microinjection of vasopressin into the locus coeruleus of conscious rats.
    Berecek KH, Olpe HR, Jones RS, Hofbauer KG.
    Am J Physiol; 1984 Oct 24; 247(4 Pt 2):H675-81. PubMed ID: 6496709
    [Abstract] [Full Text] [Related]

  • 33. Leukotriene D4 inhibits cardiovascular responses to sympathetic stimulation, angiotensin and vasopressin in the pithed spontaneously hypertensive rats.
    Bayorh MH, Zukowska-Grojec Z, Kopin IJ, Feuerstein G.
    J Pharmacol Exp Ther; 1984 Oct 24; 231(1):85-90. PubMed ID: 6491978
    [Abstract] [Full Text] [Related]

  • 34. Cardiovascular responses to noradrenaline microinjection in the ventrolateral periaqueductal gray of unanesthetized rats.
    Pelosi GG, Tavares RF, Antunes-Rodrigues J, Corrêa FM.
    J Neurosci Res; 2008 Feb 15; 86(3):712-9. PubMed ID: 17893924
    [Abstract] [Full Text] [Related]

  • 35. The effects of noradrenaline, B-HT 920, methoxamine, angiotensin II and vasopressin on mean circulatory filling pressure in conscious rats.
    Pang CC, Tabrizchi R.
    Br J Pharmacol; 1986 Oct 15; 89(2):389-94. PubMed ID: 2877700
    [Abstract] [Full Text] [Related]

  • 36. [Effect of vasopressin in the rostral ventrolateral medulla on pressor response induced by dPAG stimulation].
    Feng K, Guo XQ.
    Sheng Li Xue Bao; 1997 Oct 15; 49(5):491-6. PubMed ID: 9813486
    [Abstract] [Full Text] [Related]

  • 37. Pressor doses of vasopressin result in only transient elevations in plasma peptide levels.
    Yosten GL, Samson WK.
    Peptides; 2012 Feb 15; 33(2):342-5. PubMed ID: 22227112
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.